A new report from the Central Brain Tumor Registry of the United States (CBTRUS) and the American Cancer Society – and funded in part by NBTS – found that while overall incidence rates of malignant brain tumors declined slightly (0.8% annually) from 2008 through 2017 in the U.S., five-year survival rates remain unacceptably low. This data continues to underscore the urgency with which we must work to realize more treatments, longer survival, and a better quality of life for those diagnosed with brain tumors.
|